Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea.
A placebo-controlled trial of intramuscular iron dextran prophylaxis for two-month-old infants was carried out on the north coast of Papua New Guinea where there is high transmission of malaria. The results indicate that the placebo group became relatively iron deficient whereas the iron dextran group had adequate iron stores and, in the absence of malaria, a higher mean haemoglobin. However in the iron dextran group there was a higher prevalence of malaria, as judged by parasite and spleen rates at 6- and 12-month follow-up; a lower haemoglobin associated with malaria when compared with the placebo group and a greater reticulocytosis in response to malaria infection. Within the placebo group it was noticed that the malaria rates were lower at follow-up in those infants who had had a low birth haemoglobin. In neither group was there apparent suppression of marrow activity in the presence of malaria. Malaria infection in both groups was associated with a significantly raised serum ferritin level and transferrin saturation. Over-all these data give evidence for a protective role of iron deficiency against malaria and would argue against the injudicious use of iron replacement in areas where malaria is endemic.
D002986:Clinical Trials as Topic; D004198:Disease Susceptibility; D004311:Double-Blind Method; D004906:Erythrocyte Count; D005293:Ferritins / Q000097:blood; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007223:Infant; D017053:Infection Control; D007501:Iron / Q000009:adverse effects*; D000090463:Iron Deficiencies; D008288:Malaria / Q000097:blood / Q000517:prevention & control*; D010219:Papua New Guinea; D012156:Reticulocytes; D012621:Seasons
D006454:Hemoglobins; D005293:Ferritins; D007501:Iron